Stock Upgrades Today See Wall Street Boost Confidence

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  17 Nov 2025
 

•   ALAB  
   
  -2.30%
•   AMC  
   
  -0.92%
•   ANRO  
   
  -4.80%
•   DELL  
   
  -1.92%
•   RBRK  
   
  -0.26%

$ALAB Astera Labs caught a meaningful tailwind today as Northland upgraded the stock to Outperform citing accelerating momentum from its Scorpio X platform. With AI infrastructure demand expanding at a pace that continues to surprise even seasoned analysts the firm sees Astera positioned squarely at the intersection of next generation connectivity and hyperscale data acceleration. The upgrade reflects growing confidence that Scorpio X will not only deepen Astera relationships with cloud providers but also expand its total addressable market far beyond previous expectations.

$AMC appeared in the spotlight through Saltire Capitals strong Q3 2025 performance update where its MDI subsidiary reported double digit growth in cinema related sales and sustained demand from major partners like IMAX Regal and AMC itself. While the announcement was not a traditional analyst upgrade it effectively served as a signal of strengthening fundamentals across cinema infrastructure. With theater operators continuing to invest in premium auditoriums and laser projection upgrades AMC benefits indirectly through accelerated industry modernization and renewed commitment to premium experiences.

$ANRO Alto Neuroscience received fresh bullish coverage as BTIG initiated the stock with a Buy rating and a 27 dollar price target more than doubling Fridays close. The analyst highlighted Altos differentiated precision psychiatry approach and its substantial optionality as candidates advance. The coverage initiation underscores a broader shift in sentiment around neuroscience driven therapeutics where data rich targeting platforms are capturing analyst attention and investor appetite simultaneously.

$DELL Dell entered the news cycle through a notable downgrade from Morgan Stanley which shifted the stock from Overweight to Underweight. While this is technically the opposite of an upgrade it provides important context for traders assessing sector rotation and expectations around enterprise demand normalization. The reduced price target reflects concerns that Dells hyperscale and AI uplift may be peaking in the near term. As a result the stock now sits in a more contentious space where sentiment is cooling even as long term transformation narratives continue to evolve.

$RBRK Rubrik gained momentum today following an upgrade that further fueled optimism around the cybersecurity growth runway. Analysts pointed to strengthening demand for data security automation and cloud native protection capabilities which places Rubrik in an increasingly strategic position as enterprises race to secure expanding cloud footprints. The upgrade suggests Rubrik blend of subscription revenue and mission critical tooling could drive higher than expected operating leverage ahead.

$ROKU ROKU landed Strong Buy list signaling renewed bullish enthusiasm around the streaming and connected TV ecosystem. With ROKU added alongside other high momentum tickers analysts appear increasingly confident in the ability to monetize platform scale even as media budgets remain uneven. The firms placement on the list reinforces the narrative that ROKU continues to outpace competitors in engagement metrics and advertising platform stickiness.

$WH Wyndham Hotels drew attention through the unveiling of a major 60 million dollar transformation at its Rio Mar resort a move that bolsters the brands premium identity and long term value proposition. While not an explicit analyst upgrade the sweeping renovation supports stronger forward expectations for RevPAR growth and higher margin mix shift. Investors watching travel leisure names may view the update as a signal of solid capital deployment and improving global travel demand dynamics.

$WVE Wave Life Sciences saw its Buy rating reaffirmed by Jefferies with analysts emphasizing improved competitive positioning following a setback reported by a key rival in RNA editing therapeutics. The maintained rating reflects confidence in Waves platform and the widening advantage as peers struggle to demonstrate protective activity. With sentiment improving and upside potential still substantial analysts view WVE as one of the more compelling small cap biotech setups heading into upcoming readouts.

$YUM Yum Brands secured an upgrade from TD Cowen following recent strategic clarity including developments tied to the Pizza Hut business review. The firm sees operational improvements and a more focused global strategy supporting higher confidence in near term performance. The upgrade underscores Yum ability to navigate shifting consumer patterns while leveraging scale and brand recognition to drive stabilization and incremental growth across its global franchise network.

View All Headlines